Novocure (NVCR) Misses Q2 EPS by 2c, Miss on Revenues

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $40.38 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance